Physician profile
Peter Frederick Ford
NPI 1891917431
$17,853.23
in general payments reported to CMS, 2019-2025
12 companies · $206 in 2025
The $206 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,807 · 2020: $6,723 · 2021: $3,497 · 2022: $3,170 · 2023: $208 · 2024: $243 · 2025: $206.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $657.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $656.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $10,271.14 | 2019-2020 | |
| Medtronic, INC. | $6,278.37 | 2021-2025 | Venaseal, Closurefast |
| Bard Peripheral Vascular, INC. | $431.74 | 2022-2025 | Venclose Maven Catheter |
| Janssen Pharmaceuticals, INC | $272.33 | 2019-2022 | |
| Boston Scientific Corporation | $173.62 | 2021-2025 | Varithena Administration Pack |
| Biocompatibles, INC. | $171.56 | 2019 | |
| Organogenesis INC. | $118.92 | 2022-2025 | Via Matrix, Affinity |
| Endologix LLC | $48.75 | 2022 | |
| Smith+Nephew, INC. | $35.52 | 2022 | |
| Abbott Laboratories | $20.90 | 2021 | |
| Exact Sciences Corporation | $16.22 | 2023 | Cologuard Collection Kit |
| Cashflow Solutions, LLC | $14.16 | 2024 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Ford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.